Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B DeLise

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Immunity, Inflammation and Disease|June 26, 2024
Reactivity of HLADR antibody manifests expression of surface MHC II molecules on peripheral blood T lymphocytes in new world monkeysSriram Chitta, Bharti P Nehete, Ashley B Delise, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 21, 2004
Different embryo-fetal toxicity effects for three VLA-4 antagonistsF Crofts, M Pino, B DeLise, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 21, 2004
Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonistsF Crofts, S Rohatagi, M Pino, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Immunity, Inflammation and Disease|June 26, 2024
Reactivity of HLADR antibody manifests expression of surface MHC II molecules on peripheral blood T lymphocytes in new world monkeysSriram Chitta, Bharti P Nehete, Ashley B Delise, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 21, 2004
Different embryo-fetal toxicity effects for three VLA-4 antagonistsF Crofts, M Pino, B DeLise, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 21, 2004
Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonistsF Crofts, S Rohatagi, M Pino, et al.
Pageof 1